General MedicationsINTRAMUSCULAR, INTRAVENOUSGeneric
WELLCOVORIN
LEUCOVORIN CALCIUM
Standard Dose
EQ 5MG BASE/ML (EQ 5MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview WELLCOVORIN is listed in Drugs@FDA under application 087439 (ANDA).
Marketing status: Discontinued Active ingredient LEUCOVORIN CALCIUM Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - EQ 5MG BASE/ML (EQ 5MG BASE/ML) Sponsor GLAXOSMITHKLINE Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview WELLCOVORIN is listed in Drugs@FDA under application 087439 (ANDA). Marketing status: Discontinued Active ingredient LEUCOVORIN CALCIUM Form and strength SOLUTION;INTRAMUSCULAR, INTRAVENOUS - EQ 5MG BASE/ML (EQ 5MG BASE/ML) Sponsor GLAXOSMITHKLINE Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.